The cost of selected tuberculosis control measures at hospitals with a history of Mycobacterium tuberculosis outbreaks.
OBJECTIVE
To determine the cost of nonrespirator-related tuberculosis (TB) control measures at several hospitals, following publication of the Centers for Disease Control and Prevention (CDC)'s revised TB infection control guidelines.


METHODS
Infection control (IC) and TB coordinators obtained cost information on tuberculin skin-test (TST) programs, addition of IC and employee health service (EHS) personnel, and the retrofit or new construction of environmental controls.


METHODS
Four hospitals with, and one community hospital without, prior nosocomial multidrug-resistant TB transmission.


RESULTS
During the study period, the TST program costs remained constant at four of five hospitals and increased at one hospital (median 1994 TST program cost: $5,568; range, $2,393-$44,902). Additional IC or EHS personnel were hired at four of five hospitals (median cost increase, $125,500; range, $63,000-$228,000). The median cost of new construction or new equipment purchases (ie, sputum induction booths, ultraviolet lights, or portable high-efficiency particulate air filters) at study hospitals was $163,000 (range, $45,000-$524,000) and $70,000 (range, $31,000-$93,000), respectively.


CONCLUSIONS
Costs associated with implementing control measures similar to those recommended in the CDC TB IC guidelines varied widely by hospital. Engineering controls involved the largest capital outlay, but increases in personnel were the largest continuing cost. These costs represent improvements made to upgrade selected aspects of hospital TB control programs, not the cost of an optimal TB control program.
Kellerman
S
S
Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Tokars
J I
JI
Jarvis
W R
WR
D003428:Cross Infection / Q000453:epidemiology / Q000517:prevention & control*; D004196:Disease Outbreaks; D017721:Hospital Costs / Q000706:statistics & numerical data*; D006764:Hospitals, Community / Q000191:economics; D006801:Humans; D017053:Infection Control / Q000191:economics* / Q000592:standards; D017410:Practice Guidelines as Topic; D018088:Tuberculosis, Multidrug-Resistant / Q000453:epidemiology / Q000517:prevention & control*; D014397:Tuberculosis, Pulmonary / Q000453:epidemiology / Q000517:prevention & control*; D014481:United States / Q000453:epidemiology